Thursday, March 07, 2013
Dr. Jay Berman performs historic uterine fibroid surgery at DMC Sinai-Grace Berry Surgery Center
FARMINGTON HILLS – Jay M. Berman, M.D., FACOG, a Detroit Medical Center gynecologist with the Wayne State University Physician Group, has performed thefirst commercial procedure in the United States using the new AcessaTM technology for the treatment of uterine fibroids at the Berry Surgery Center in Farmington Hills, an outpatient facility affiliated with DMC Sinai-Grace Hospital.
Uterine fibroids are non-cancerous tumors that develop in the uterus. While the condition is common, symptoms vary and some women suffer severe discomfort, pain and heavy bleeding. According to the U.S. Centers for Disease Control and Prevention, fibroids are the leading cause for hysterectomy procedures worldwide.
The revolutionary AcessaTM technology is used in a minimally invasive, same-day laparoscopic procedure to deliver radiofrequency energy to fibroids. After treatment, the fibroid is re-absorbed by the surrounding tissue.
“Approximately 50 percent to 70 percent of women have uterine fibroids,” Dr. Berman said. “Before the AccessaTM technology, treatment involved cutting through layers of healthy tissue to gain access to the fibroids, or removing the uterus completely through a hysterectomy. However, research shows the majority of women choose to suffer through their symptoms rather than undergo surgery.”
AcessaTM allows the surgeon to treat only the fibroids, while preserving normal function of the uterus. Patients typically go home the same day with little pain, and are back to regular activities within five days.
“Any technology that gives us the ability to give women choices, in this case that spares the uterus and avoids the need for hysterectomy, has merit,” said L. Andrea Coleman, M.D., chief of Obstetrics and Gynecology at DMC Sinai-Grace Hospital. “Sinai-Grace and the DMC have some of the best physicians in
the country, and this is evidence of that. I applaud us for always being on the forefront of technology and for doing the work that is required to stay there.”
Dr. Berman is a board-certified gynecologist specializing in fibroid treatment and endometrial ablation. The associate professor of Obstetrics and Gynecology at the Wayne State University School of Medicine was one of 11 surgeons involved in the U.S. clinical research trials of the AcessaTM procedure, which were also conducted at the Berry Surgery Center. Dr. Berman also serves as associate chief medical officer for clinical operations for WSUPG and as director of Wayne State University School of Medicine’s Division of Gynecology.
“We are extremely happy that Dr. Berman and the Wayne State University Physician Group have begun introducing their patients to the Acessa Procedure,” said Jeffrey M. Cohen, Halt Medical CEO. “The Acessa Procedure represents a major breakthrough in addressing one of the biggest unmet needs in women’s health, uterine fibroids. Acessa is the only medical device that can be used by gynecologists to treat all fibroid symptoms and types.”
The AcessaTM Technology was developed by Halt Medical Inc., a California-based medical device company. The U.S. Food and Drug Administration approved AcessaTM for the treatment of uterine fibroids in November.
Patients who are interested in more information about the AcessaTM procedure can call 248-352-8200.